The role of somatostatin analogues in the medical management of insulinomas is unclear. We describe an elderly patient with clinical and biochemical features of endogenous hyperinsulinism attributable to a benign islet B cell disorder whose incapacitating neuroglycopaenic symptoms responded dramatically to octreotide 50 pg subcutaneously at 2200 h each night. Octreotide suppressed inappropriate plasma concentrations ofinsulin thereby preventing fasting hypoglycaemia. Fasting concentrations of proinsulin, and 32-33 split proinsulin, as determined by two-site monoclonal antibody-based immunoradiometric assays, were also suppressed by octreotide.
Introduction
Surgical excision remains the definitive treatment for benign functioning insulinomas"2 with longterm medical treatment usually being reserved for patients who refuse surgery or those in whom surgery is deemed inappropriate.3 However, the therapeutic options for medical management of endogenous hyperinsulinism remain relatively limited. The anti-hypertensive agent diazoxide has been used successfully to inhibit insulin secretion by insulin-secreting tumours but is commonly associated with significant adverse effects including fluid retention and hirsutism. 4 The efficacy of alternative drugs such as verapamil and betablockers remains unclear. 4 Octreotide is a long-acting analogue of somatostatin with potent suppressive effects on a number ofendogenous hormones including insulin.5 6 However, the role of octreotide in the management of benign insulinomas remains to be clarified. The literature contains conflicting reports of efficacy7 contrasting with worsening of fasting hypoglycaemia.48'0 We describe an elderly man with clinical and biochemical features of an insulinsecreting tumour whose symptoms were abolished by a single nightly dose of octreotide. Octreotide suppressed fasting concentrations of circulating insulin and islet B cell conversion intermediates thereby preventing hypoglycaemia.
Methods
Plasma immunoreactive insulin," proinsulin, and C-peptide concentrations were determined using double antibody radioimmunoassays (RIAs). Plasma concentrations of insulin, proinsulin, and 32-33 split proinsulin were determined using highly specific two-site monoclonal antibodybased immunoradiometric assays (IRMAs) with between assay coefficients of variation (CVs) of 15% or less and detection limits ranging from 0.8 to 2.5 pmol/1.12 Venous plasma glucose concentrations were determined using glucose oxidase methods on fluoride-oxalate samples.
Patient
An 80 year old man presented with a 2 week history of episodic confusion and agitation occurring each morning before breakfast. Two weeks earlier he had undergone a transurethral prostatectomy for benign disease which was complicated by an acute postoperative Gram-negative septicaemia. Past medical history included asymptomatic chronic atrial fibrillation treated with digoxin. There was no other relevant drug history nor any history of alcohol consumption.
Physical Approximately 80% of insulinomas are reported to secrete an excess of proinsulin relative to immunoreactive insulin.'6"7 However, the literature concerning immunoreactive insulin and proinsulin concentrations in insulin-secreting tumours is largely derived from radioimmunoassays characterized by significant crossreactivity between insulin and proinsulin-like molecules.'8"'9 We therefore measured plasma insulin and islet B cell conversion intermediates using two-site immunoradiometric assays. While the role of specific assays of proinsulin-like molecules in the diagnosis of insulinomas has yet to be clearly established several observations provide support for the diagnosis of insulinoma in our patient. First, fasting plasma insulin concentration was not suppressed in the presence of hypoglycaemia.20 Second, fasting proinsulin concentration was elevated during hypoglycaemia.2' Similarly, the molar ratio of (proinsulin + 32-33 split proinsulin) to (insulin + proinsulin + 32-33 split proinsulin) expressed as a percentage was elevated at 25.1 % compared to 9.4% ± 1.0 (mean ± s.e. in healthy middle aged subjects).22 Third, the fasting plasma insulin: glucose ratio was elevated at 34% (normal:
10.1 ± 1.0%),22 a biochemical feature characteristic of states of endogenous hyperinsulinism.4
Octreotide had a marked effect on circulating concentrations ofislet B cell products with suppression of fasting concentrations of insulin, proinsulin, and 32-33 split proinsulin, the latter being suppressed below the detection limit of the assay. The ratio of total proinsulin-like molecules to insulin was not significantly altered by octreotide. Since proinsulin-like molecules are characterized by lower biological activities than insulin23 it seems likely that suppression of insulin concentrations were primarily responsible for the improvement observed in fasting plasma glucose concentrations. Whether the response of an insulinoma to octreotide is dependent on the relative secretion of insulin or proinsulin-like molecules or whether the response of solitary islet B cell tumours is comparable with that of multiple islet adenomatosis or adult nesidioblastosis4 has not been determined.
In summary, a single nightly dose of octreotide eliminated fasting hypoglycaemia in our patient through suppression of circulating insulin concentrations. Fasting concentrations of proinsulin and 32-33 split proinsulin were also suppressed. The case reported indicates that octreotide can be an effective and well-tolerated long-term medical treatment for certain patients with endogenous hyperinsulinism.
Introduction
Pallid syncope (reflex anoxic seizure) is a fairly common childhood event that is probably underrecognized. It has been reported that 4.6-46.2% of a childhood population suffer breath-holding attacks of some form and 1% have pallid syncope, the others having the more commonly diagnosed and better understood cyanotic variety.' Pallid syncope is distinguished by the child's obvious pallor during the attack, together with other signs suggestive of vagal overactivity. In a small number of patients with very frequent attacks, treatment with atropine has been shown to be effective. 2 The diagnosis can be further established by the demonstration of vagal asystole from eyeball compression, a procedure said to be safe and free of complications, the cardiac standstill being selflimiting. 3 These events are often very dramatic and frightening to the parents, but fundamentally harmless; we report the case of a child with a previous history of attacks suggestive of pallid syncope, who suffered an unexplained cardiac arrest.
Case report A 21 month old child had been entirely well in the past. He had a history of frequent episodes of breath-holding, starting at the age of about 6 months, during which he is said to have become profoundly pale and his parents report having been deeply alarmed by these in the past, although no hospital contact had resulted. The patient is the only child of the couple, neither of whom has a family history of breath-holding or sudden infant death syndrome.
On the occasion of his admission, he is said to have been well. His parents reported that they had had an argument during the early evening and a training shoe was thrown; this accidentally struck the child on the left side ofthe abdomen. He started to cry, held his breath, arched his back and his eyes rolled upwards. His father picked him up, only for him to become pale and limp.
One parent began mouth-to-mouth resuscitation whilst the other called an ambulance. The paramedically trained crew arrived 4 minutes later and found him in asystole. He was intubated and cardiopulmonary resuscitation was commenced in the ambulance en route to hospital; atropine and adrenaline were given via the endotracheal tube without success. The accident and emergency department was reached 25 minutes after the first call.
